Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compare the effect of TIVA and isoflurane on liver enzyme activity in laparoscopic cholecystectomy
IRCT20200122046216N1Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of isoflurane in cholelithiasis (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoint: Change in liver enzyme activity. Started Jul 2019; status: completed.
02
Drugs
isoflurane
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on IRCT20200122046216N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200122046216N1.